Business Maverick: Lilly weight-loss drug copycats dealt blow as shortage ends

Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs that became popular when patients couldn’t find the brand-name medicines.